Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Silver nanoparticles as a new generation of antimicrobials.

Here, we present a review of the antibacterial effects of silver nanomaterials, including proposed antibacterial mechanisms and possible toxicity to higher organisms. For purpose of this review, silver nanomaterials include silver nanoparticles, stabilized silver salts, silver–dendrimer, polymer and metal oxide composites, and silver-impregnated zeolite and activated carbon materials. While there is some evidence that silver nanoparticles can directly damage bacteria cell membranes, silver nanomaterials appear to exert bacteriocidal activity predominantly through release of silver ions followed (individually or in combination) by increased membrane permeability, loss of the proton motive force, inducing de-energization of the cells and efflux of phosphate, leakage of cellular content, and disruption DNA replication. Eukaryotic cells could be similarly impacted by most of these mechanisms and, indeed, a small but growing body of literature supports this concern. Most antimicrobial studies are performed in simple aquatic media or cell culture media without proper characterization of silver nanomaterial stability (aggregation, dissolution, and re-precipitation). Silver nanoparticle stability is governed by particle size, shape, and capping agents as well as solution pH, ionic strength, specific ions and ligands, and organic macromolecules—all of which influence silver nanoparticle stability and bioavailability. Although none of the studies reviewed definitively proved any immediate impacts to human health or the environment by a silver nanomaterial containing product, the entirety of the science reviewed suggests some caution and further research are warranted given the already widespread and rapidly growing use of silver nanomaterials.

https://link.springer.com/content/pdf/10.1007%2Fs11051-010-9900-y.pdf

A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment

Green synthesis of metal nanoparticles using plants

The major strategies for designing surfaces that prevent fouling due to proteins, bacteria, and marine organisms are reviewed. Biofouling is of great concern in numerous applications ranging from biosensors to biomedical implants and devices, and from food packaging to industrial and marine equipment. The two major approaches to combat surface fouling are based on either preventing biofoulants from attaching or degrading them. One of the key strategies for imparting adhesion resistance involves the functionalization of surfaces with poly(ethylene glycol) (PEG) or oligo(ethylene glycol). Several alternatives to PEG-based coatings have also been designed over the past decade. While protein-resistant coatings may also resist bacterial attachment and subsequent biofilm formation, in order to overcome the fouling-mediated risk of bacterial infection it is highly desirable to design coatings that are bactericidal. Traditional techniques involve the design of coatings that release biocidal agents, including antibiotics, quaternary ammonium salts (QAS), and silver, into the surrounding aqueous environment. However, the emergence of antibiotic- and silver-resistant pathogenic strains has necessitated the development of alternative strategies. Therefore, other techniques based on the use of polycations, enzymes, nanomaterials, and photoactive agents are being investigated. With regard to marine antifouling coatings, restrictions on the use of biocide-releasing coatings have made the generation of nontoxic antifouling surfaces more important. While considerable progress has been made in the design of antifouling coatings, ongoing research in this area should result in the development of even better antifouling materials in the future.

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201001215

Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms.

In the present scenario, pharmaceutical and biomedical sectors are facing the challenges of continuous increase in the multidrug-resistant (MDR) human pathogenic microbes. Re-emergence of MDR microbes is facilitated by drug and/or antibiotic resistance, which is acquired way of microbes for their survival and multiplication in uncomfortable environments. MDR bacterial infections lead to significant increase in mortality, morbidity and cost of prolonged treatments. Therefore, development, modification or searching the antimicrobial compounds having bactericidal potential against MDR bacteria is a priority area of research. Silver in the form of various compounds and bhasmas have been used in Ayurveda to treat several bacterial infections since time immemorial. As several pathogenic bacteria are developing antibiotic resistance, silver nanoparticles are the new hope to treat them. This review discusses the bactericidal potential of silver nanoparticles against the MDR bacteria. This multiactional nanoweapon can be used for the treatment and prevention of drug-resistant microbes.

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2672.2012.05253.x

Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria

Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole

We report extracellular mycosynthesis of silver nanoparticles by Fusarium acuminatum Ell. and Ev. (USM-3793) isolated from infected ginger (Zingiber officinale). An aqueous silver nitrate solution was reduced to metallic silver when exposed to F. acumi- natum cell extract leading to the appearance of a brown color within 15-20 minutes. The color is due to the formation of silver nanoparti- cles and the excitation of surface plasmons. The optical spectrum showed the plasmon resonance at 420 nm and analysis by transmission electron microscopy confirmed the presence of silver nanoparticles. The nanoparticles produced were spherical with a broad size distribu- tion in the range of 5-40 nm with average diameter of 13 nm. The reduction of the silver ions occurs probably by a nitrate-dependent re- ductase enzyme, which we found to be present in the extra-cellular medium. We tested the silver particles for their broad-band antibacte- rial activity on different human pathogens. We observed efficient antibacterial activity against multidrug resistant and highly pathogenic bacteria, including multidrug resistant Staphylococcus aureus, Salmonella typhi, Staphylococcus epidermidis, and Escherichia coli. The synthesis of silver nanoparticles by the fungus F. acuminatum may therefore serve as a simple, cheap, eco-friendly, reliable and safe method to produce an antimicrobial material.

Aniket Gade

Papers

Silver nanoparticles as a new generation of antimicrobials.

Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria

Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole

Mycosynthesis of Silver Nanoparticles Using the Fungus Fusarium acuminatum and its Activity Against Some Human Pathogenic Bacteria

Exploitation of Aspergillus niger for Synthesis of Silver Nanoparticles